TABLE 1.
Characteristics of patients receiving kidney replacement therapy in Australia and New Zealand
| Characteristics | Cardiac/vascular deaths | Non‐cardiac/vascular deaths | Alive | Total | ||||
|---|---|---|---|---|---|---|---|---|
| n | (%) a | n | (%) a | n | (%) a | n | (%) a | |
| Total (%) b | 8492 | (14) | 25 826 | (42) | 26 505 | (44) | 60 823 | (100) |
| Age at KRT (years) | ||||||||
| ≤29 | 151 | (2) | 1024 | (4) | 3913 | (15) | 5088 | (8) |
| 30–49 | 1212 | (14) | 4364 | (17) | 8231 | (31) | 13 807 | (23) |
| 50–64 | 3045 | (36) | 8701 | (34) | 8234 | (31) | 19 980 | (33) |
| 65–74 | 2562 | (30) | 7357 | (28) | 3923 | (15) | 13 842 | (23) |
| ≥75 | 1522 | (18) | 4380 | (17) | 2204 | (8) | 8106 | (13) |
| Median [IQR] | 64 | [55, 72] | 63 | [52, 71] | 51 | [38, 63] | 59 | [46, 69] |
| Sex | ||||||||
| Female | 3125 | (37) | 11 248 | (44) | 10 669 | (40) | 25 042 | (41) |
| Male | 5367 | (63) | 14 578 | (56) | 15 836 | (60) | 35 781 | (59) |
| Year of KRT | ||||||||
| ≤1995 | 3220 | (38) | 8674 | (34) | 3488 | (13) | 15 382 | (25) |
| 1996–2005 | 3627 | (43) | 11 440 | (44) | 7048 | (27) | 22 115 | (36) |
| 2006–2013 | 1645 | (19) | 5712 | (22) | 15 969 | (60) | 23 326 | (38) |
| Country | ||||||||
| Australia | 7242 | (85) | 21 750 | (84) | 22 459 | (85) | 51 451 | (85) |
| New Zealand | 1250 | (15) | 4076 | (16) | 4046 | (15) | 9372 | (15) |
| Ethnicity c | ||||||||
| European | 6898 | (81) | 20 125 | (78) | 19 002 | (72) | 46 025 | (76) |
| East Asian | 388 | (5) | 1355 | (5) | 2612 | (10) | 4357 | (7) |
| Aboriginal Australian | 481 | (6) | 1862 | (7) | 1904 | (7) | 4247 | (7) |
| Maori | 467 | (6) | 1619 | (6) | 1154 | (4) | 3240 | (5) |
| Pacific Island peoples | 211 | (2) | 728 | (3) | 1320 | (5) | 2259 | (4) |
| African and Middle Eastern | 41 | (0.5) | 117 | (0.5) | 334 | (1) | 492 | (1) |
| Peoples of the Americas | 0 | (<0.1) | 4 | (<0.1) | 15 | (<0.1) | 19 | (<0.1) |
| Other | 6 | (<0.1) | 16 | (<0.1) | 165 | (1) | 187 | (0.3) |
| Body mass index (mg/kg2) | ||||||||
| Underweight (<18.5) | 254 | (3) | 1052 | (4) | 1396 | (5) | 2702 | (4) |
| Normal (18.5–24.9) | 2632 | (31) | 8383 | (32) | 8851 | (33) | 19 866 | (33) |
| Overweight (25.0–29.9) | 2227 | (26) | 6652 | (26) | 7762 | (29) | 16 641 | (27) |
| Obese (≥30) | 1608 | (19) | 5085 | (20) | 7079 | (27) | 13 772 | (23) |
| Not collected | 1771 | (21) | 4654 | (18) | 1417 | (5) | 7842 | (13) |
| Comorbidities at KRT | ||||||||
| Cerebrovascular disease | 1561 | (18) | 4078 | (16) | 2037 | (8) | 7676 | (13) |
| Diabetes | 2855 | (34) | 10 321 | (40) | 8541 | (32) | 21 717 | (36) |
| Coronary artery disease | 4364 | (53) | 10 318 | (40) | 6103 | (23) | 20 785 | (34) |
| Peripheral artery disease | 2628 | (31) | 7111 | (28) | 3634 | (14) | 13 373 | (22) |
| Previous malignancy | 1819 | (21) | 8096 | (31) | 5873 | (22) | 15 788 | (26) |
| Smoking status | ||||||||
| Current/former | 4235 | (50) | 12 259 | (47) | 11 895 | (45) | 28 389 | (47) |
| Never | 2683 | (32) | 9617 | (37) | 13 561 | (51) | 25 861 | (43) |
| Not collected | 1574 | (19) | 3950 | (15) | 1049 | (4) | 6573 | (11) |
| Cause of kidney failure | ||||||||
| Diabetes | 2151 | (25) | 8023 | (31) | 6735 | (25) | 16 909 | (28) |
| Hypertension/renal artery disease | 1853 | (22) | 3079 | (12) | 2332 | (9) | 7264 | (12) |
| Glomerulonephritis/IgA nephropathy | 1923 | (23) | 5914 | (23) | 8795 | (33) | 16 632 | (27) |
| Polycystic kidney disease | 415 | (5) | 1279 | (5) | 2309 | (9) | 4003 | (7) |
| Other d | 2150 | (25) | 7531 | (29) | 6334 | (24) | 16 015 | (26) |
| Incident KRT modality | ||||||||
| Peritoneal dialysis | 2644 | (31) | 8134 | (32) | 7069 | (27) | 17 847 | (29) |
| Haemodialysis | 5825 | (69) | 17 562 | (68) | 17 946 | (68) | 41 333 | (68) |
| Transplant | 24 | (0.3) | 131 | (0.5) | 1494 | (6) | 1649 | (3) |
| Transplanted during study | 1181 | (14) | 3951 | (15) | 10 852 | (41) | 15 984 | (26) |
| Transplanted ever | 1205 | (14) | 4082 | (16) | 12 346 | (47) | 17 633 | (29) |
Abbreviation: KRT, kidney replacement therapy.
a
Column percentages.
b
Row percentages.
c
As defined by the Australian Standard Classification of Cultural and Ethnic Groups, 2019.
d
Primarily uncertain diagnosis (7%), analgesic nephropathy (5%), reflux nephropathy (5%).